| 英文别名 |
(S)-2-Amino-5-(3-propylguanidino)pentanoic acid;Nω-Propyl-L-Arginine;N-OMEGA-PROPYL-L-ARGININE;(2S)-2-amino-5-[(N'-propylcarbamimidoyl)amino]pentanoic acid;L-Ornithine,N5-[imino(propylamino)methyl]-;NW-PROPYL-L-ARGININE;Nω-Propyl-L-arginine hydrochloride;3AR;N5-[IMino(propylaMino)Methyl]-L-ornithinehydrochloride;Tocris-1200;AKOS015911666;N.omega.-propyl-L-Arginine;HY-102062;Q27088088;(S)-2-Amino-5-(3-propylguanidino)pentanoicacid;SCHEMBL1004634;137361-05-8;N-?-Propyl-L-Arginine;C9H20N4O2.HCl;CS-0022933;(S)-2-Amino-5-(N''-propyl-guanidino)-pentanoic acid;Nomega-Propyl-L-arginine;N;N5-[Imino(propylamino)methyl]-L-ornithine;AOMXURITGZJPKB-ZETCQYMHSA-N;CHEMBL107528;BDBM235688;O-Propyl-L-arginine;2(S)-2-Amino-5-(N-propylguanidino)pentanoic acid;Nomegapropyl-L-arginine;J-007011;omega-propyl-l-arginine;NS00068628;Nomega-Propyl-L-arginine hydrochloride;hDDAH inhibitor, 2b;L-Ornithine, N5-[imino(propylamino)methyl]-;(2S)-2-Amino-5-(N'-propylcarbamimidamido)pentanoic acid;N5-[Imino(propylamino)methyl]-L-ornithine hydrochloride;G7F9U4R2AC;GTPL6525;N- omega -Propyl-L-Arginine;(2S)-2-amino-5-(N''-propylcarbamimidamido)pentanoic acid;NCGC00025034-01;DTXSID30332245;N?-Propyl-L-Arginine;BDBM50240716;HB0466;DA-66289;n?propyl-L-arginine;Nw-Propyl-L-Arginine;N-omega-Propyl-L-arginine |